BrightPath Biotherapeutics Co., Ltd. (TYO:4594)
69.00
+6.00 (9.52%)
Mar 6, 2026, 3:30 PM JST
TYO:4594 Market Cap
TYO:4594 has a market cap or net worth of 9.09 billion as of March 6, 2026. Its market cap has increased by 141.66% in one year.
Market Cap
9.09B
Enterprise Value
7.84B
Revenue
1.11M
Ranking
n/a
PE Ratio
n/a
Stock Price
69.00
Market Cap Chart
Since October 22, 2015, TYO:4594's market cap has decreased from 13.23B to 9.09B, a decrease of -31.29%. That is a compound annual growth rate of -3.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 9.09B | 70.05% |
| Dec 30, 2025 | 5.35B | 37.06% |
| Dec 30, 2024 | 3.90B | -28.70% |
| Dec 29, 2023 | 5.47B | -13.00% |
| Dec 30, 2022 | 6.29B | 7.22% |
| Dec 30, 2021 | 5.87B | -35.18% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| K Pharma,Inc. | 10.11B |
| StemCell Institute | 8.87B |
| MEDINET | 8.27B |
| OncoTherapy Science | 7.91B |
| ADR120S | 7.87B |
| CellSource | 7.65B |
| Chiome Bioscience | 7.43B |
| Linical | 7.16B |